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AmpD is a bacterial amidase involved in the recycling of cell-wall frag-
ments in Gram-negative bacteria. Inactivation of AmpD leads to derepres-
sion of b-lactamase expression, presenting a major pathway for the
acquisition of constitutive antibiotic resistance. Here, we report the NMR
structure of AmpD from Citrobacter freundii (PDB accession code 1J3G).
A deep substrate-binding pocket explains the observed specificity for
low molecular mass substrates. The fold is related to that of bacteriophage
T7 lysozyme. Both proteins bind zinc at a conserved site and require zinc
for amidase activity, although the enzymatic mechanism seems to differ
in detail. The structure-based sequence alignment identifies conserved
features that are also conserved in the eukaryotic peptidoglycan recog-
nition protein (PGRP) domains, including the zinc-coordination site in
several of them. PGRP domains thus belong to the same fold family and,
where zinc-binding residues are conserved, may have amidase activity.
This hypothesis is supported by the observation that human serum
N-acetylmuramyl-L-alanine amidase seems to be identical with a soluble
form of human PGRP-L.
q 2003 Published by Elsevier Science Ltd
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Introduction
Peptidoglycan, the major constituent of bacterial
cell walls, confers rigidity, shape and resistance
against osmotic lysis. The exceptional stability of
this macromolecule results from peptide cross-
links between the glycan chains composed of alter-
nating units of N-acetyl-glucosamine (GlcNAc)
and substituted N-acetyl muramic acid (MurNAc)
residues. In Gram-negative bacteria, MurNAc resi-
dues are derivatised by L-alanyl-g-D-glutamyl-
meso-diaminopimelyl-D-alanine (L-Ala-D-Glu-m-
A2pm-D-Ala) linked to the sugar via an amide
bond between the L-Ala amino group and the
carboxyl group of the muramyl residue. Cross-
links between two adjacent glycan chains form
between m-A2pm in one peptide and D-Ala in
another.
Cell growth and division require continuous
peptidoglycan remodelling by peptidoglycan
hydrolases. In Escherichia coli and, probably, most
other Gram-negative bacteria, 40–50% of the
peptidoglycan is degraded during each generation
by autolytic enzymes and 90% of the degraded
products are recycled.1 – 3 AmpD is a cytosolic
amidase (EC 3.5.1.28) involved in this recycling.
AmpD specifically cleaves the amide bond
between the lactyl group of N-acetylmuramic
acid and the a-amino group of the L-alanine in
degradation products containing an anhydro
N-acetylmuramyl moiety, such as 1,6-anhydro-
MurNAc-tripeptides, -tetrapeptides and GlcNAc-
1,6-anhydroMurNAc-tri- and -tetrapeptides. In
contrast, cytoplasmic precursors of peptidoglycan,
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such as UDP-MurNAc-tripeptide and UDP-
MurNAc-pentapeptide, are not hydrolyzed by
AmpD.4,5
Importantly, high intracellular levels of
uncleaved 1,6-anhydroMurNAc-tripeptides allos-
terically induce the transcriptional activator
AmpR, resulting in derepression of b-lactamase
expression in bacteria with inducible b-
lactamases.4 As AmpD activity is not essential for
bacteria, inactivating mutations of AmpD present
a straightforward mechanism by which bacteria
can gain constitutive b-lactam resistance. In fact,
the high-volume use of third-generation cephalo-
sporins has resulted in the selection of constitu-
tively b-lactam resistant AmpD2 populations of
Enterobacter, Serratia, Morganella, Citrobacter, Pseudo-
monas and Providencia. These present a serious pro-
blem in hospitals and intensive care units, where
resistance levels against third-generation cephalo-
sporins above 40% were reported for, e.g. Entero-
bacter cloacae.6
To date, over 50 bacterial amidases have been
identified by genomic sequencing and classified
as presumable N-acetylmuramyl-L-alanine ami-
dases, including functional homologues of
AmpD as well as more general cell-wall hydro-
lases. The only 3D structure determined for any
member of this class of enzymes is the crystal
structure of bacteriophage T7 lysozyme,7,8 which
displays only about 20% sequence identity with
AmpDs. Here, we report the 3D structure of
AmpD from Citrobacter freundii, which is the bio-
chemically best characterised AmpD and almost
90% identical in sequence with Escherichia coli
AmpD, with most differences confined to the N
and C termini. AmpD is shown to require zinc
for enzymatic activity and a model of the
enzyme-substrate complex is established to
explain its substrate specificity. Structure-based
sequence alignment of AmpD and T7 lysozyme
indicates that peptidoglycan recognition protein
(PGRP) domains have the same fold and sub-
strate-binding site, including zinc-binding resi-
dues. This suggests hydrolytic activity for
several of the PGRP domains, although no enzy-
matic activity has been found for the PGRP
domains characterised to date. PGRP domains
represent the only group of eukaryotic proteins
known with significant sequence homology to
AmpD and T7 lysozyme. They attracted much
current interest, since some of them were shown
to trigger immune responses by recognition of
bacterial cell walls.9 – 13
Results and Discussion
Solution structure of C. freundii AmpD and
comparison to T7 lysozyme
The fold of AmpD comprises three b-sheets,
four a-helices, and one 310-helical turn (Figure
1(a)). They include residues 3–5 (b1), 7–8 (b2),
12–14 (b3), 31–33 (b4), 46–53 (a1), 62–69 (a2),
76–79 (b5), 83–87 (b6), 100–102 (b7), 105–107
(b8), 115–117 (b9), 127–143 (a3), 147–149 (310),
151–152 (b10) and 171–177 (a4), as identified by
the Kabsch–Sander algorithm in the majority of
the NMR conformers.14 A search of the protein
data bank (PDB) with the program DALI15
revealed T7 lysozyme7 as the only structural rela-
tive, with an r.m.s.d. of 3.3 A˚ for 120 aligned Ca
atoms. The structural conservation is most apparent
for strands b4, b5, b6, b9, and b10 in AmpD, which
form a mostly parallel b-sheet of the same topology
as in T7 lysozyme. In AmpD, however, this sheet is
extended by a sixth strand, b3 (Figure 1(a) and (b)).
Similarly, helices 1, 3 and 4 are conserved between
AmpD and T7 lysozyme, while a2 and the 310-helical
turn have no counterpart in T7 lysozyme. In
addition, AmpD contains two sheets composed of
two antiparallel b-strands each (b1/b2 and b7/b8,
respectively) that are not present in the T7 lysozyme
structure.
All peptide bonds are in the trans conformation.
In particular, the trans conformation was assumed
for Pro165, although the corresponding residue in
T7 lysozyme, Pro131, forms a cis-peptide bond.
This was based on the observation of a weak
sequential Ha–CdH2 NOE. The presence or absence
of a sequential Ha–Ha NOE, expected for a cis-
peptide bond, could not be verified due to chemi-
cal shift degeneracy. As the sequence alignment
shows insertions and deletions nearby (Figure 2),
the conformation of this proline residue is not
necessarily conserved.
Inductively coupled plasma mass spectrometry
(ICPMS) showed that AmpD binds a single
divalent zinc ion. In the NMR structure, this Zn2þ
is bound by residues homologous to the Zn2þ-bind-
ing residues of T7 lysozyme (Figure 2). Like T7
lysozyme, AmpD is inactivated by metal chelators
(C. G. & B. J., unpublished results).
The 15N-chemical shifts of all eight histidine
side-chains were assigned and indicated that the
side-chains of histidines 34, 61, 75, 96 and 154
are uncharged at pH 5.5 (15N chemical shifts at
about 250 ppm and 220 ppm for free and Zn2þ-
coordinating nitrogen atoms, respectively) with
hydrogen atoms only on Ne2, while the side-
chains of histidines 18, 69 and 183 were proto-
nated (15N chemical shifts below 200 ppm).16
His75 and His96 are completely buried like the
corresponding histidine residues in T7 lysozyme.
The chemical shifts indicate that His34 and
His154 coordinate Zn2þ via their Nd1 atom, in
complete analogy to T7 lysozyme. His61 at the
amino-terminal end of helix a2 is solvent-exposed
yet unprotonated, presumably due to the dipolar
field of this helix. In analogy to T7 lysozyme,
where Cys130 represents the third zinc coordinat-
ing residue, Asp164 was assumed to coordinate
the zinc ion in AmpD. This assumption is sup-
ported by the fact that the Asp164Glu and
Asp164Ala mutants are enzymatically inactive
(C. G. & B. J., unpublished results).17
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Figure 1. Solution structure of AmpD and comparison with T7 lysozyme. (a) Ribbon representation of AmpD. The
b-strands and a-helices are numbered as in Figure 2. White and yellow numbers distinguish strands and helices,
respectively. The zinc ion is shown in purple. (b) Ribbon representation of T7 lysozyme (PDB code 1LBA). Second-
ary-structure elements homologous to AmpD are coloured as in (a). (c) Stereo view of AmpD, showing a superposition
of the backbone atoms in the 20 conformers representing the NMR structure (Table 1), in the same orientation as in (a).
Numbers identify sequence positions. (d) Stereo view of the AmpD conformer closest to the mean structure of the 20
conformers shown in (c), using a heavy-atom representation in the same orientation as in (c). The polypeptide back-
bone is drawn in green. The following colors were used for the side-chains: blue, Arg, Lys, positively charged His;
red, Glu, Asp; yellow, Ala, Cys, Ile, Leu, Met, Phe, Pro, Trp, Val; gray, Asn, Gln, Ser, Thr, Tyr, uncharged His. The
zinc ion is shown as a purple sphere, with the side-chains of the coordinating residues His34, His154 and Asp164
drawn in bold. Black spheres mark the Ca positions of those residues, where point mutations have been found in con-
stituitively b-lactamase expressing bacteria.17
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Interaction with a substrate analogue and
model of the enzyme-substrate complex
While no high-affinity inhibitor of AmpD is
known, MurNAc-L-Ala-D-Gln (Bachem, Switzer-
land) displayed an inhibitory effect in enzymatic
assays (C. G. & B. J., unpublished results). 15N-
HSQC spectra recorded for 15N-labelled AmpD in
the presence of a 100-fold excess of this substrate
analogue, however, did not reveal any significant
shift of amide resonances, indicating that any bind-
ing interaction must be weak. Yet, significant line
broadening was observed for some of the reson-
ances, most significantly the side-chain HN of the
Zn-coordinating residue His154, which broadened
beyond detection (data not shown). No broadening
could be detected for any of the other histidine resi-
dues, but a line broadening by ca 30% was observed
for the Zn-coordinating residue Asp164. Further-
more, the amide resonance of Tyr63 was broadened
about twofold. These data strongly suggest that the
Zn2þ marks the location of the active site. Further
small line broadenings were observed for the
amide groups of Lys162, Arg22, Tyr19, and Leu70,
which could be due to interactions with the peptide
segment of the substrate analogue.
In order to check whether the site with the Zn2þ
could accommodate a substrate molecule and
hence mark the active site, one conformer of the
ensemble of NMR structures was selected to
model the enzyme-substrate complex (Figure 3).
As AmpD positively discriminates anhydromura-
mic acid versus muramic acid derivatives, the
carbohydrate moiety was assumed to be in inti-
mate contact with the enzyme. The model shows
that the carbonyl oxygen atom of the scissile
amide bond can be placed in close proximity to
the Zn2þ, with the anhydroMurNAc moiety resid-
ing in a recognition pocket. The accuracy of the
model is insufficient to pinpoint specific inter-
molecular interactions that would explain the
preference of AmpD for anhydroMurNAc over
MurNAc. However, the availability of a recog-
nition pocket of limited size would explain the
specificity of AmpD for small substrate molecules.
The pocket appears to be sufficiently deep that it
Figure 2. Multiple alignment of the amino acid sequences of Citrobacter freundii AmpD (AmpD), Haemophilus influen-
zae AmpD (Haein), bacteriophage T7 lysozyme (T7) and peptidoglycan recognition domains from Drosophila (SA and
SB1) and human (human L). Sequence numbers are shown for AmpD and T7 lysozyme. Bars indicate the locations of
helices and b-strands in AmpD and T7 lysozyme, respectively. Filled triangles identify Zn2þ-coordinating residues in
T7 lysozyme and AmpD. Open triangles identify catalytically important residues in T7 lysozyme.7 Bold characters in
the three PGRP domains highlight residues that are uncharged (including His) in all 26 untruncated PGRP domain
sequences reported by Werner et al. and Liu et al.13,19 Filled squares identify residues with a side-chain solvent-accessi-
bility of ,10% in both AmpD and T7 lysozyme.
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could accommodate a GlcNAc-1,6-anhydroMur-
NAc moiety, but not a larger carbohydrate unit or
the anabolic compound UDP-MurNAc-pentapep-
tide. The existence of this pocket is determined lar-
gely by the loop connecting strand 4 and helix 1,
which assumes a very different conformation in
AmpD and T7 lysozyme (Figure 1(a) and (b)),
although there is no insertion or deletion in this
amino-acid segment (Figure 2). The structural
difference between AmpD and T7 lysozyme in
this region is significant, as the conformation of
this loop is conserved between free7 and polymer-
ase-complexed8 T7 lysozyme, and it appears to be
well defined in AmpD. The different loop confor-
mation, together with the additional strands b7
and b8 (Figure 1(a) and (b)), is probably an import-
ant determinant of the specificity of AmpD for
small substrate molecules, while T7 lysozyme is
able to act on polymeric substrates.
The model predicts only superficial attachment
of the peptide part to the protein surface, explain-
ing the weak discrimination between peptide moi-
eties of different lengths.5 In Figure 3, the terminal
end of the peptide was modeled to contact Lys162,
as mutations at this site reduced enzymatic activity
(C. G. & B. J., unpublished results). However, the
NMR data with the substrate analogue suggest
that the terminal end could also contact Arg22
and nearby residues (Figure 3). There is thus no
evidence for particular specificity for meso-diami-
nopimelic acid in the peptide segment, although
this amino acid is characteristic of Gram-negative
bacteria with a cell-wall recycling system.
Besides the three zinc-coordinating residues and
Lys128, Tyr46 had been identified as a catalytically
important residue in T7 lysozyme (Figure 2). Its
side-chain oxygen atom is about 5.3 A˚ from the
zinc ion and mutation to phenylalanine completely
abrogates enzymatic activity.7 In AmpD, Tyr63 pro-
vides the closest hydroxyl group, which is located
at a slightly longer distance in most of the NMR
conformers (Figure 3). If residues 40–46 of T7 lyso-
zyme were left-shifted in the sequence alignment
of Figure 2 by 11 residues, Tyr63 in AmpD would
align with Tyr46 in T7 lysozyme. Such an align-
ment is, however, not supported by the structures.
Tyr63 in AmpD is located in a helix that has no
counterpart in T7 lysozyme (Figure 2) and
approaches the active site from a different angle.
Furthermore, mutation to phenylalanine retains
10% of the enzymatic activity (C. G. & B. J., unpub-
lished results). Clearly, both enzymes seem to use
the Zn2þ to polarise the scissile bond of the sub-
strate, but the enzymatic mechanism seems to dif-
fer in detail.
AmpD2 mutations
AmpDs from different bacteria are highly hom-
ologous, such as the AmpD from Haemophilus influ-
enzae (Figure 2), and their structures must be very
similar to that of C. freundii AmpD. Therefore,
point mutations that inactivate the AmpD from
one bacterial species are probably also deleterious
in C. freundii AmpD. A recent compilation of inacti-
vation mutations from nine enterobacteria iden-
tified residues 1, 7, 33, 37, 80, 82, 83, 94, 95, 102,
117, 121, 127, 134, 146, 158, 164, 171 and 172 as
sites of inactivating point-mutations capable of
triggering constitutive b-lactamase expression.17
The spatial distribution of these residues does not
highlight the location of the active site (Figure
1(d)), except that the mutation frequency of the
active-site residue Asp164 was outstanding.17 For
most of the mutated residues, the side-chain sol-
vent exposure is less than 25%, i.e. their mutation
could plausibly destabilise the protein. Residues 1,
121, 127, 158 and 172 are, however, highly solvent
exposed. Mutation of Met1 presumably interferes
with protein expression. Asp121 is within 10 A˚ of
the active site. The Asp127Gly mutation breaks a
salt-bridge with Lys173. Inactivation by the
mutations Ala158Glu (reported by Stapleton
et al.18) and Ala172Leu, however, seems to require
some unknown biological rather than structural
explanation.
Amidase activity in PGRP domains
The delineation of conserved secondary struc-
ture elements between AmpD and T7 lysozyme
allows an improved alignment with the PGRP
domains. A total of 26 different full-length PGRP
domains have been reported by Werner et al. and
Liu et al.13,19 Structural conservation is suggested
strongly by the observation that residues for
which the side-chains are buried in both AmpD
and T7 lysozyme tend to be conserved
Figure 3. Model of the AmpD-substrate complex. The
solvent-accessible surface is shown with the following
color code for different chemical groups: yellow, hydro-
phobic; gray, hydrophilic; red, negatively charged; blue,
positively charged. The zinc atom is displayed as a pur-
ple sphere. The side-chains of the Zn2þ-coordinating resi-
dues and of Tyr63 were excluded from the surface
calculation and drawn with green lines instead. The sub-
strate, 1,6-anhydro MurNAc-L-alanyl-g-D-glutamyl-meso-
diaminopimelic acid, is drawn in a line representation
(blue) with carbonyl and carboxyl bonds in red.
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hydrophobic and uncharged residues in PGRP
domains (Figure 2). On the basis of the number of
insertions and deletions in the alignment, PGRP
domains are related to T7 lysozyme more closely
than to AmpD. For example, they lack the sheet
composed of strands b7 and b8. The absence of
this sheet correlates with the ability of T7 lysozyme
and PGRPs to bind macromolecular rather than
low molecular mass substrates. On the other hand,
they seem to be more like AmpD in the loop
between strand b9 and helix a3 (Figure 2). Even
helix a4 seems to be present in PGRP domains, as
indicated by the periodical pattern of consistently
uncharged residues. This pattern is, however, out-
of-frame compared to AmpD and T7 lysozyme,
suggesting a different orientation with respect to
the protein core.
A previously published alignment of PGRP
domains with bacteriophage T3 lysozyme (which
is 97% identical in sequence with T7 lysozyme)
suggested the absence of conserved Zn2þ-binding
residues,11 but the sequence similarity was so low
that its significance is not universally accepted.19
Our new, improved alignment, however, clearly
reveals conserved Zn2þ-binding residues in the sol-
uble Drosophila SB1 protein, in the membrane-
attached human L protein and in several other
PGRPs shown in the alignments by Werner et al.
and Liu et al.13,19 In contrast, these Zn2þ-binding
residues are not conserved in the Drosophila SA
protein (Figure 2) or in numerous other PGRPs
(not shown), which thus seem to be devoid of a
metal-binding site. Interestingly, this group of
PGRPs seems capable of binding to carbohydrates
and exerting antibacterial activity in a peptido-
glycan and zinc-independent way.20 – 22
All PGRP domains with a conserved Zn2þ-bind-
ing site (six of 26 different PGRP domains) also
have a conserved tyrosine residue13,19 that corre-
sponds to the catalytically critical residue Tyr46 in
T7 lysozyme, and a histidine residue correspond-
ing to His96 in AmpD that is buried near the active
site. In T7 lysozyme, Lys128 is the only residue
besides Tyr46 that has been shown to be cata-
lytically important. It is also conserved in AmpD
(Lys162), although it is not one of the zinc-coordi-
nating residues. The PGRP domains with putative
zinc-binding site all have threonine at this position.
In T7 lysozyme, the Lys128Thr mutant reduces
amidase activity but does not fully inactivate.7
There is incidental evidence for amidase activity
by at least one member of the PGRP family, as a
soluble form of human PGRP-L19 (denoted human
L in Figure 2) seems to be identical with the pre-
viously characterised serum N-acetylmuramyl-L-
alanine amidase (MA).23 The sequence of the 15
N-terminal residues of MA determined by chemi-
cal microsequencing23 corresponds exactly to that
of human PGRP-L, devoid of its first 21 residues.
No other protein in the human genome matches
this amino acid sequence. MA is an abundant, gly-
cosylated, dimeric enzyme with a molecular mass
of 73 kDa per monomeric subunit. Considering
the increase in molecular mass due to glycosyla-
tion, this is in good agreement with the molecular
mass of human PGRP-L calculated from its amino
acid sequence (60 kDa for residues 22–576). MA
was reported to require high concentrations of
MgCl2 (10 mM) for optimum substrate binding
and enzymatic activity, while Zn2þ-dependence
was not tested.23 In view of our results and the
fact that physiological concentrations of Mg2þ in
blood are only 0.8–1.2 mM, this enzyme may
work better with Zn2þ than with Mg2þ.
In conclusion, amidase activity is highly plaus-
ible for all PGRP domains that are capable of bind-
ing Zn2þ. The structural homologies established
here will allow the informed design of active-site
mutations in PGRP domains that interfere with
function without disrupting their structure. It is
remarkable how, in the course of evolution, a clas-
sical bacterial household enzyme has been
recruited and turned against bacteria by bacterio-
phages and by the eukaryotic immune system.
Materials and Methods
AmpD expression and purification
For the preparation of isotope-labelled samples, the
gene of C. freundii AmpD was cloned into pET-9a and
transformed into E. coli BL21(DE3)/pLysS cells (Invitro-
gen), where AmpD expressed as a cytoplasmic protein.
Uniformly 15N and 15N/13C-labelled protein samples
were prepared overnight at 37 8C in 100 ml of 15N
Celtone (Martek Biosciences Corporation) or 15N/13C
Celtone broth supplemented with 50 mg ml21 kanamycin
and 30 mg ml21 chloramphenicol. These cultures were
used to inoculate 5 l of M9 minimal medium, containing
0.05% (w/v) thiamine, 0.001% (w/v) biotin, 0.01%
(w/v) choline chloride, 0.001% (w/v) folic acid, 0.01%
(w/v) niacinamide, 0.002% (w/v) pyridoxal, 0.001%
(w/v) riboflavin, 4 mM MgSO4, 13 mM FeSO4, 20 mM
15NH4Cl and glucose (30 mM unlabelled glucose or
9 mM 13C-glucose). Similarly, a sample with 10% biosyn-
thetic fractional 13C-labeling was prepared using a 1:9
mixture of 13C-labelled and 12C-labelled glucose at a
total concentration of 30 mM. Growth was accomplished
at 30 8C. When the cell density reached an A600 value of
1, IPTG (1 mM final concentration) was added and
growth continued overnight.
After induction, the cells were harvested by centrifu-
gation (8300g, 15 minutes, 4 8C), washed with 150 mM
NaCl and resuspended in buffer A (20 mM phosphate
buffer (pH 7.0) containing 1 mM DTT). Cell lysis was
achieved with the help of a cell disintegrator (Serie Z,
Constant System, Warwick, UK) at 4 8C with a pressure
of 1.9 kbar (1 bar ¼ 105 Pa). Benzonase (5 units/litre of
culture) and Pefabloc (0.1 mg/ml, final concentration)
were added to cell lysates. The insoluble material was
removed by centrifugation at 20,000g for 15 minutes at
4 8C. The supernatant was dialyzed overnight against
buffer A. After dialysis, the lysate was centrifuged at
20,000g for 15 minutes at 4 8C, microfiltered on 0.70 mm
and 0.45 mm Millipore filters and loaded onto a Q-Sepha-
rose column (2.6 cm £ 30 cm, 160 ml, Amersham Phar-
macia Biotech, Uppsala, Sweden) equilibrated in buffer
A. The column was eluted with a linear gradient of
NaCl (720 ml) from 0 M to 1 M. The peak fractions
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containing the AmpD amidase were pooled, concen-
trated to 10 ml by ultrafiltration on a 5000 Da cutoff
Amicon membrane and applied onto a molecular sieve
column of Sephacryl S100 HR (2.6 cm £ 95 cm, 500 ml,
Amersham Pharmacia Biotech) equilibrated in buffer
A. The fractions containing the amidase were collected
and concentrated. After dialysis against 1.6 M
(NH4)2SO4, the enzyme was purified further by a Source
15 ISO column (1.6 cm £ 10 cm, 20 ml, Amersham
Pharmacia Biotech), eluting with a linear gradient from
1.5 M to 0 M (NH4)2SO4. The fractions containing
AmpD were collected and dialyzed against buffer and
concentrated by ultrafiltration. After addition of NaN3
(1 mM, final concentration), the enzyme was stored at
4 8C. The protein content of the column fractions was
monitored by SDS-PAGE. The concentration of AmpD
was determined from its absorbance at 280 nm, using an
extinction coefficient of 31,960 M21 cm21. Typical yields
were 12–18 mg of pure protein/litre of medium for
unlabelled AmpD and 2–8 mg/l for isotope-labelled
AmpD.
Metal content analysis
Pure protein (1 ml of 48 mM) was dialysed overnight
against 250 ml of 10 mM Hepes (pH 7.0) in doubly dis-
tilled water. The zinc content of the enzyme was
measured by ICPMS.
NMR spectroscopy
NMR spectra were recorded at 31 8C at pH 5.5 and 7.0,
using ,0.3 mM solutions of AmpD in 95% H2O/5%
2H2O or 100%
2H2O at a
1H NMR frequency of 600 MHz
on a Bruker DMX 600 NMR spectrometer. Samples were
prone to irreversible precipitation. The sample stability
at pH values below 7 was significantly improved by the
addition of 2 mM ZnSO4. Most of the NOE restraints
were collected from a homonuclear NOESY spectrum
recorded at 800 MHz on a Varian Unity INOVA NMR
spectrometer with a sample of unlabelled AmpD (40 ms
mixing time, t1max ¼ 63 ms and t2max ¼ 128 ms; 3-9-19
water suppression, one week total recording time).
Figure 4. 15N-HSQC spectrum of C. freundii AmpD. The spectrum was recorded using an 0.3 mM sample of uni-
formly 15N-labelled AmpD at pH 5.5 and 31 8C in the presence of 2 mM ZnSO4 at 600 MHz
1H NMR frequency. Back-
bone resonances are assigned with the amino acid codes and sequence numbers. Side-chain resonances are labelled
in addition with the greek letters of the respective side-chains. The second peak of the NdH2 group of Asn109 is outside
the plot region. The inset is an expansion of the spectral region identified by a box.
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Resonance assignments (Figure 4) were obtained from
standard 3D HNCO, HNCA, HN(CO)CA, CBCA(CO)
NH, NOESY-15N-heteronuclear single quantum corre-
lation (HSQC), total correlated spectroscopy (TOCSY)-
15N-HSQC and H(C)CH-TOCSY and HC(CH)-TOCSY24
experiments. Further 1H resonance assignments were
obtained from double quantum filtered (DQF)-COSY,
clean-TOCSY (60 ms mixing time) and NOESY (40 ms
and 100 ms mixing time) spectra recorded with
unlabelled protein. Stereospecific assignments of CbH2-
protons were obtained by a 3D HNHB spectrum. Stereo-
specific assignments of diastereotopic methyl groups
were obtained from analysis of a 13C-HSQC spectrum of
the 10% biosynthetically fractionally 13C-labelled sample.
Side-chain 15N resonances of histidine residues were
assigned using 15N-HMQC spectra recorded according
to Pelton et al.16 using a J-evolution delay of 17 ms for
simultaneous detection of 1JNH and long-range
2JNH and
3JNH correlations. Residual dipolar couplings
1JNH were
measured with the help of different concentrations of
Pf1 phages. Coupling constants 3J(HN,Ha) couplings
were measured by a CT-HMQC-HN experiment.25
The total recording time for all experiments was about
two months. 3J(Ha,Hb) couplings were estimated as
11.0 and 4.0 Hz (^3.0 Hz), respectively, when COSY,
TOCSY and NOESY cross-peaks indicated the
presence of large and small couplings, respectively,
together with staggered conformations around the
Ca–Cb bond.
Structure calculations
The cross-peaks in the NOESY spectra were assigned
and integrated using the program XEASY.26 The NMR
structure was calculated using the program DYANA,27
starting from 80 random conformers. The residue library
was modified to accommodate the zinc ion. Distance
constraints were introduced between Zn2þ and the coor-
dinating atoms, which were modelled after the crystal
structure of carboxypeptidase (PDB code 1QBR). The 20
conformers with the lowest residual restraint violations
were energy minimised in water using the programme
OPAL with standard parameters.28
Table 1 shows an overview of the restraints used and
structural statistics. The Ramachandran plot was ana-
lyzed using PROCHECK-NMR.29 No residue was con-
sistently in a forbidden region of the Ramachandran in
all 20 conformers.
Secondary structure elements and r.m.s.d. values were
calculated using the program MOLMOL,30 which was
used to create Figures 1 and 3. Side-chain solvent accessi-
bilities were measured with a spherical probe of 1.4 A˚
radius and calculated as a percentage of the accessibil-
ities measured for a fully extended side-chain of residue
X in a helical Gly-X-Gly peptide.31 The values obtained
were averaged over the 20 NMR conformers.
Model building
The geometry of the 1,6-anhydroMurNAc-tripeptide
was optimised at the quantum chemistry semi-empirical
AM1 level32 using the program Gaussian98 (Revision
A.6, Gaussian, Pittsburgh). The start position of the com-
plex was built empirically by docking the substrate in
the cavity with the program InsightII (Biosym, San
Diego). Thereafter, the geometry of the substrate com-
plexes was optimised at the molecular mechanics level33
with the Amber force-field using the program Discover
(Biosym, San Diego). The geometry optimisations were
performed without water, using a dielectric constant of
2 and taking the threshold for convergence to be the
maximum force fixed at 0.02 kcal mol21 A˚21.
Data Bank accession codes
The coordinates of the 20 energy-refined DYANA con-
formers of AmpD have been deposited in the PDB with
the accession code 1J3G. The NMR chemical shifts
were deposited at the BioMagResBank (BMRB) under
accession code 5483.
Acknowledgements
We thank Christine Jacobs, Johan Weigelt and
Andrew Torda for initial protein samples, NMR
measurements and sequence alignments, respect-
ively, and ASLA (Riga, Latvia) for a gift of Pf1
phages. We thank Bengt Persson for searching the
public and Celera human genome data bases for
the MA peptide. This work was supported by the
Belgian program on Interuniversity Poles of Attrac-
tion initiated by the Federal Office for Scientific,
Technical and Cultural Affaires (PAI no P5/33),
the Fond National de la Recherche Scientifique
(FNRS, cre´dit aux chercheurs no 1.5201.02), the
Swedish Research Council and the Swedish NMR
Centre. B. J. is an FNRS associate researcher and
C. G. is a fellow of the Fonds pour la Formation a`
la Recherche dans l’Industrie et l’Agriculture
(FRIA, Brussels, Belgium). The ICPMS measure-
ments were performed by the Laboratoire de la
Sante´ et de l’Environnement, Institut Malvoz de la
Province de Lie`ge, Lie`ge, Belgium.
Table 1. Structural statistics for the NMR conformers
Parameter Value
No. assigned NOE cross-peaks 2820
No. non-redundant NOE upper-distance limits 1879
No. scalar coupling constantsa 361
No. residual 1H–15N dipolar couplings 145
No. dihedral-angle restraints 488
Intra-protein AMBER energy (kcal mol21) 27640 ^ 90
Maximum NOE-restraint violations (A˚) 0.10 ^ 0.00
Maximum dihedral-angle restraint violations
(deg.)
3.3 ^ 0.4
r.m.s.d. to the mean for N,Ca and C0 (A˚)b 0.61 ^ 0.10
r.m.s.d. to the mean for all heavy-atoms (A˚)b 0.99 ^ 0.11
Ramachandran plot appearancec
Most favoured regions (%) 70.2
Additionally allowed regions (%) 28.2
Generously allowed regions (%) 1.6
Disallowed regions (%) 0.1
a 146 3J(HN–Ha), 215 3J(Ha–Hb).
b For residues 2–180.
c From PROCHECK-NMR.29
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Note added in proof: Peptidoglycan degrading N-acetylmuramoyl-L-alanine amidase activity was recently
demonstrated experimentally for PGRP-SC1B (Mellroth, P., Karlsson, J. & Steiner, H., J. Biol. Chem. 278,
7059–7064, 2003).
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